Esperion Therapeutics (NASDAQ:ESPR) and OPKO Health (NASDAQ:OPK) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.
Risk and Volatility
Esperion Therapeutics has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Comparatively, OPKO Health has a beta of 1.98, indicating that its share price is 98% more volatile than the S&P 500.
Insider & Institutional Ownership
28.5% of OPKO Health shares are held by institutional investors. 7.7% of Esperion Therapeutics shares are held by company insiders. Comparatively, 40.9% of OPKO Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Esperion Therapeutics and OPKO Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Esperion Therapeutics | 2 | 3 | 3 | 1 | 2.33 |
OPKO Health | 0 | 0 | 2 | 0 | 3.00 |
Esperion Therapeutics presently has a consensus target price of $52.8889, indicating a potential upside of 87.88%. OPKO Health has a consensus target price of $9.00, indicating a potential upside of 103.62%. Given OPKO Health's stronger consensus rating and higher possible upside, analysts plainly believe OPKO Health is more favorable than Esperion Therapeutics.
Valuation and Earnings
This table compares Esperion Therapeutics and OPKO Health's top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Esperion Therapeutics | $148.36 million | 5.19 | $-97,170,000.00 | ($3.59) | -7.67 |
OPKO Health | $901.90 million | 3.24 | $-314,920,000.00 | ($0.41) | -10.63 |
Esperion Therapeutics has higher earnings, but lower revenue than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Esperion Therapeutics, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Esperion Therapeutics and OPKO Health's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Esperion Therapeutics | -46.15% | -629.88% | -41.43% |
OPKO Health | -9.79% | -2.61% | -1.80% |
Summary
OPKO Health beats Esperion Therapeutics on 10 of the 15 factors compared between the two stocks.